Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Eleanor Briggs

Director of policy and campagins, National AIDS Trust

Recent stories

  • NHS England’s backtracking on its refusal to fund pre-exposure prophylaxis (PrEP) funding is a step forward for public healthSubscription

    21 APR 2016

    In March 2016, NHS England removed HIV prevention drug pre-exposure prophylaxis (PrEP) from its official commissioning process — just months before it was due to conclude. After looking at NHS England’s decision, the National AIDS Trust was certain we had a legal basis to challenge this. We started those proceedings on 12 April 2016. By 18 April, NHS England responded saying it would reconsider its decision. If it all goes well, this means PrEP could be back on the cards. This i

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.